Logo image of GRNQ

GREENPRO CAPITAL CORP (GRNQ) Stock Fundamental Analysis

NASDAQ:GRNQ - Nasdaq - US39540F3091 - Common Stock - Currency: USD

1.03  +0.01 (+0.49%)

After market: 1.0201 -0.01 (-0.96%)

Fundamental Rating

1

We assign a fundamental rating of 1 out of 10 to GRNQ. GRNQ was compared to 225 industry peers in the Capital Markets industry. GRNQ has a bad profitability rating. Also its financial health evaluation is rather negative. GRNQ has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

In the past year GRNQ has reported negative net income.
GRNQ had a negative operating cash flow in the past year.
In the past 5 years GRNQ reported 4 times negative net income.
In the past 5 years GRNQ always reported negative operating cash flow.
GRNQ Yearly Net Income VS EBIT VS OCF VS FCFGRNQ Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -5M -10M

1.2 Ratios

GRNQ has a worse Return On Assets (-98.96%) than 99.09% of its industry peers.
Looking at the Return On Equity, with a value of -138.06%, GRNQ is doing worse than 91.32% of the companies in the same industry.
Industry RankSector Rank
ROA -98.96%
ROE -138.06%
ROIC N/A
ROA(3y)-30.46%
ROA(5y)-26.38%
ROE(3y)-36.77%
ROE(5y)-39.7%
ROIC(3y)N/A
ROIC(5y)N/A
GRNQ Yearly ROA, ROE, ROICGRNQ Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -50 -100 -150

1.3 Margins

Looking at the Gross Margin, with a value of 83.96%, GRNQ belongs to the top of the industry, outperforming 86.76% of the companies in the same industry.
In the last couple of years the Gross Margin of GRNQ has grown nicely.
GRNQ does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 83.96%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.24%
GM growth 5Y10.56%
GRNQ Yearly Profit, Operating, Gross MarginsGRNQ Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -100 -200 -300 -400

3

2. Health

2.1 Basic Checks

GRNQ has less shares outstanding than it did 1 year ago.
GRNQ has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, GRNQ has a worse debt to assets ratio.
GRNQ Yearly Shares OutstandingGRNQ Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2M 4M 6M
GRNQ Yearly Total Debt VS Total AssetsGRNQ Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 5M 10M 15M 20M

2.2 Solvency

GRNQ has an Altman-Z score of -5.98. This is a bad value and indicates that GRNQ is not financially healthy and even has some risk of bankruptcy.
GRNQ's Altman-Z score of -5.98 is on the low side compared to the rest of the industry. GRNQ is outperformed by 94.98% of its industry peers.
A Debt/Equity ratio of 0.00 indicates that GRNQ is not too dependend on debt financing.
The Debt to Equity ratio of GRNQ (0.00) is better than 87.21% of its industry peers.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -5.98
ROIC/WACCN/A
WACCN/A
GRNQ Yearly LT Debt VS Equity VS FCFGRNQ Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 5M 10M 15M

2.3 Liquidity

A Current Ratio of 1.35 indicates that GRNQ should not have too much problems paying its short term obligations.
GRNQ's Current ratio of 1.35 is in line compared to the rest of the industry. GRNQ outperforms 56.16% of its industry peers.
GRNQ has a Quick Ratio of 1.35. This is a normal value and indicates that GRNQ is financially healthy and should not expect problems in meeting its short term obligations.
GRNQ has a Quick ratio of 1.35. This is comparable to the rest of the industry: GRNQ outperforms 56.16% of its industry peers.
Industry RankSector Rank
Current Ratio 1.35
Quick Ratio 1.35
GRNQ Yearly Current Assets VS Current LiabilitesGRNQ Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2M 4M 6M

0

3. Growth

3.1 Past

GRNQ shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -354.59%.
The Revenue for GRNQ has decreased by -17.10% in the past year. This is quite bad
GRNQ shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -3.75% yearly.
EPS 1Y (TTM)-354.59%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-118%
Revenue 1Y (TTM)-17.1%
Revenue growth 3Y15.62%
Revenue growth 5Y-3.75%
Sales Q2Q%-49.56%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
GRNQ Yearly Revenue VS EstimatesGRNQ Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2M 4M 6M
GRNQ Yearly EPS VS EstimatesGRNQ Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for GRNQ. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
GRNQ Price Earnings VS Forward Price EarningsGRNQ Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
GRNQ Per share dataGRNQ EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for GRNQ!.
Industry RankSector Rank
Dividend Yield N/A

GREENPRO CAPITAL CORP

NASDAQ:GRNQ (2/20/2025, 8:24:10 PM)

After market: 1.0201 -0.01 (-0.96%)

1.03

+0.01 (+0.49%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)11-12 2024-11-12/bmo
Earnings (Next)04-28 2025-04-28
Inst Owners1.16%
Inst Owner Change9.01%
Ins Owners22.58%
Ins Owner Change0%
Market Cap7.81M
Analysts43.33
Price TargetN/A
Short Float %1.03%
Short Ratio0.27
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 2.86
P/FCF N/A
P/OCF N/A
P/B 1.62
P/tB 1.65
EV/EBITDA N/A
EPS(TTM)-0.89
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.21
FCFYN/A
OCF(TTM)-0.2
OCFYN/A
SpS0.36
BVpS0.64
TBVpS0.63
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -98.96%
ROE -138.06%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 83.96%
FCFM N/A
ROA(3y)-30.46%
ROA(5y)-26.38%
ROE(3y)-36.77%
ROE(5y)-39.7%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.24%
GM growth 5Y10.56%
F-Score3
Asset Turnover0.4
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 59.11%
Cap/Sales 3.31%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.35
Quick Ratio 1.35
Altman-Z -5.98
F-Score3
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)26.98%
Cap/Depr(5y)16.93%
Cap/Sales(3y)1.27%
Cap/Sales(5y)0.81%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-354.59%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-118%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-17.1%
Revenue growth 3Y15.62%
Revenue growth 5Y-3.75%
Sales Q2Q%-49.56%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-84.73%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y19.45%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y24.03%
OCF growth 3YN/A
OCF growth 5YN/A